Endocrinology News

Adults with Graves’ disease treated with antithyroid drugs have a higher risk for multiple types of cancer compared with the general population, according to findings published in Thyroid.

When counseling women with kidney disease about pregnancy, nephrologists and women’s health providers must emphasize intentionality.

Treatment of obesity-related HF with preserved ejection fraction with semaglutide 2.4 mg improved body weight, physical function and HF symptoms regardless of the extent of patient frailty, a speaker reported.

Hepatic steatosis was prevalent among 52% of adults with or without type 2 diabetes and no known history of metabolic dysfunction-associated steatotic liver disease, according to findings published in Obesity.

Selling a medical practice is a complex transaction that involves not only the assets of the practice itself but also implicates associated real estate.

The CDC issued a warning to health care officials, clinicians and patients about a potential risk for overdose among people ordering counterfeit prescription medications from online pharmacies.

Follow-up albuminuria testing can be an important step in kidney care following initial abnormal results from a urine protein dipstick test, according to an analysis of health records.

Shortages of tirzepatide, a GIP/GLP-1 dual agonist approved for the treatment of type 2 diabetes and obesity, have been resolved, the FDA announced.

Women with premature ovarian insufficiency and early menopause have increased multimorbidity compared with women with menopause onset at an average age of 46 to 55 years, according to findings published in Fertility and Sterility.

Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity medications with no significantly higher risk for adverse events, according to findings from a network meta-analysis published in Obesity.